AccurKardia

New York, United States

AccurKardia is an ECG-led diagnostics software company.

$2.5M raised

Dec 2025

Seed

Top Investors

Mayo ClinicMedTech InnovatorRoot NYCPopular Impact Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AccurKardia raised?

AccurKardia has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are AccurKardia's investors?

AccurKardia's investors include Mayo Clinic, MedTech Innovator, Root NYC, Popular Impact Fund.

Where is AccurKardia headquartered?

AccurKardia is headquartered in New York, United States.

What does AccurKardia do?

AccurKardia is an ECG-led diagnostics software company.

What stage is AccurKardia at?

AccurKardia is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2025.

MLA

"AccurKardia — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/accurkardia. Accessed June 7, 2026.

APA

VCBacked. (2025). AccurKardia — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/accurkardia

Wikipedia (cite web)

{{cite web |title=AccurKardia — Funding & Investors |url=https://www.vcbacked.co/company/accurkardia |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2025.